Engineered Bacteria Deliver Two-in-One Immunotherapy Directly to the Pleural Cavity in Mice
An engineered non-pathogenic bacterium carrying a PD-L1 blocker and IL-15 significantly suppressed pleural tumors and fluid buildup in a mouse ...
An engineered non-pathogenic bacterium carrying a PD-L1 blocker and IL-15 significantly suppressed pleural tumors and fluid buildup in a mouse ...
A new study reveals that PRKDC, a gene known for DNA repair, drives immune evasion in hepatocellular carcinoma by pushing ...
New research shows that triple therapy for unresectable liver cancer is associated with denser, more mature intratumoral tertiary lymphoid structures ...
Cancer researchers are turning to an unexpected set of tools—sound waves, beams of light, electrical pulses, magnetic nanoparticles and carefully ...
Researchers at the University of Reading have uncovered a compelling new approach to combat glioblastoma, the most aggressive and lethal ...
In a groundbreaking advance that promises to redefine the landscape of cancer immunotherapy, researchers have engineered a novel delivery system ...
Breast cancer continues to pose a formidable challenge in the field of oncology, especially with its propensity for metastasizing to ...
A groundbreaking advancement in the treatment of difficult-to-treat lymphomas has emerged from the research laboratories at The University of Texas ...
In a groundbreaking study published in Cell Research, researchers have unveiled a novel approach to thwart immune evasion mechanisms employed ...
In a groundbreaking study published in the Journal of Translational Medicine, a team of researchers has illuminated a critical pathway ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine